Your browser doesn't support javascript.
loading
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.
Moreau, Philippe; Chari, Ajai; Oriol, Albert; Martinez-Lopez, Joaquin; Haenel, Mathias; Touzeau, Cyrille; Ailawadhi, Sikander; Besemer, Britta; de la Rubia Comos, Javier; Encinas, Cristina; Mateos, Maria-Victoria; Salwender, Hans; Rodriguez-Otero, Paula; Hulin, Cyrille; Karlin, Lionel; Sureda Balari, Anna; Bargay, Joan; Benboubker, Lotfi; Rosiñol, Laura; Tarantolo, Stefano; Terebelo, Howard; Yang, Shiyi; Wang, Jianping; Nnane, Ivo; Qi, Ming; Kosh, Michele; Delioukina, Maria; Goldschmidt, Hartmut.
Affiliation
  • Moreau P; Hematology, University Hospital Hôtel-Dieu, Nantes, France. philippe.moreau@chu-nantes.fr.
  • Chari A; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain.
  • Martinez-Lopez J; Hospital 12 de Octubre, H12O-CNIO, Haematological Malignancies Clinical Research Unit, Universidad Complutense, CIBERONC, Madrid, Spain.
  • Haenel M; Klinikum Chemnitz, Chemnitz, Germany.
  • Touzeau C; Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Ailawadhi S; Mayo Clinic Florida, Jacksonville, FL, USA.
  • Besemer B; Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II, Tübingen, Germany.
  • de la Rubia Comos J; Hospital La Fe, School of Medicine and Dentistry, Catholic University of Valencia, Valencia, Spain.
  • Encinas C; CIBERONC, Instituto Carlos III, Madrid, Spain.
  • Mateos MV; Hospital General Universitario Gregorio Marañón (HGUGM), IiSGM, Madrid, Spain.
  • Salwender H; University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Rodriguez-Otero P; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany.
  • Hulin C; Clínica Universidad de Navarra, Pamplona, Spain.
  • Karlin L; Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France.
  • Sureda Balari A; Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
  • Bargay J; Hematology Department, Institut Català d'Oncologia - Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain.
  • Benboubker L; Hospital Universitari Son Llàtzer, IdISBa, Palma de Mallorca, Illes Balears, Spain.
  • Rosiñol L; Service d'Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire (CHRU), Tours, France.
  • Tarantolo S; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain.
  • Terebelo H; Nebraska Cancer Specialists, Omaha, NE, USA.
  • Yang S; Providence Cancer Center, Southfield, MI, USA.
  • Wang J; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Nnane I; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Qi M; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Kosh M; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Delioukina M; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Goldschmidt H; Janssen Research & Development, LLC, Spring House, PA, USA.
Blood Cancer J ; 13(1): 33, 2023 03 07.
Article de En | MEDLINE | ID: mdl-36882409
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs à plasmocytes / Myélome multiple Limites: Humans Langue: En Journal: Blood Cancer J Année: 2023 Type de document: Article Pays d'affiliation: France Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs à plasmocytes / Myélome multiple Limites: Humans Langue: En Journal: Blood Cancer J Année: 2023 Type de document: Article Pays d'affiliation: France Pays de publication: États-Unis d'Amérique